Veru to participate in fireside chat at the 2023 cantor fitzgerald global healthcare conference on september 28th, 2023

Miami, fl, sept. 20, 2023 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing novel medicines for metastatic breast cancer and for viral induced acute respiratory distress syndrome (ards), today announced that mitchell steiner, m.d., chairman, president and chief executive officer of veru, will participate in a fireside chat at the 2023 cantor fitzgerald global healthcare conference to be held at the intercontinental new york, barclay hotel in new york city on september 28th, 2023 at 10:55 a.m. et.
VERU Ratings Summary
VERU Quant Ranking